Roughly two-thirds of adults with the disease use a pump, rather than self-injecting insulin multiple times per day. Algorithmic advancements now enable the monitors to talk to the pumps in an ...

There are limitations to the bionic pancreas however. It runs on batteries which need to be replaced regularly and the pumps filled with glucagon and insulin. It also requires a certain amount of ...

Two scenarios loom on the horizon, as the epidemic of diabetes surges across the country. Scene one: even more pressure on the U.S. economy due to costs that are now over $325 billion a year and ...

Casey Fiesler had to learn to count carbs, check her glucose levels and deal with her insulin pump multiple times a ... like many with Type 1 diabetes, uses a bionic pancreas – a small patch ...

Baird last night initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target The firm believes Beta’s iLet Bionic ...

The company’s iLet Bionic Pancreas is an insulin delivery device for treating type 1 diabetes in adults and children six years of age and older. Beta Bionics is also developing Patch Pump ...

Ladenburg analyst Jeffrey Cohen initiated coverage of Beta Bionics (BBNX) with a Buy rating and $31 price target The medical device company ...